OPP002 📄 Overview A SaMD designed to passively monitor digital biomarkers from an individual's smartphone and connected wearables (e.g., typing speed, voice tone analysis during calls, sleep patterns, social interaction frequency, heart rate variability, activity levels). AI algorithms detect subtle changes indicative of impending mental health deterioration (e.g., early signs of depression, anxiety, or stress) and trigger personalized, low-intensity interventions or recommendations for professional support, all with explicit user consent and privacy controls. Key technologies: 👤 Target users: 👍 Benefits Earlier intervention and prevention of mental health crises • Reduced stigma associated with seeking mental health support • Improved overall well-being and productivity • Personalized, 'just-in-time' support • Reduced burden on mental healthcare systems Use bullets or new lines. 👎 Challenges Balancing privacy and data utility • Accuracy of biomarker interpretation in real-world, noisy data • Preventing false positives and 'over-alerting' • Establishing trust and user acceptance for passive monitoring • Integration with clinical mental health services for seamless referral 📋 Regulatory & Validation Likely Class II SaMD, potentially Class III if used for diagnosis. • Requires stringent validation of clinical sensitivity and specificity for mental health indicators. • Robust cybersecurity and privacy frameworks are non-negotiable (e.g., de-identification, secure multi-party computation). • Clear labeling of intended use (e.g., 'for monitoring and early detection' vs. 'for diagnosis').